An updated Ebola vaccine: immunogenic, but will it protect?
An updated Ebola vaccine: immunogenic, but will it protect?
复制标题
更新的埃博拉疫苗：具有免疫原性，但它能起到保护作用吗？
DOI：
10.1016/s0140-6736(15)60613-4
复制
发表时间：
2015
期刊：
影响因子：
--
通讯作者：
Falzarano,Darryl
中科院分区：
文献类型：
--
作者：
Marzi,Andrea;Falzarano,Darryl
6 Ripatti S, Tikkanen E, Orho-Melander M, et al. A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses. Lancet 2010; 376: 1393–400. 7 Hughes MF, Saarela O, Stritzke J, et al. Genetic markers enhance coronary risk prediction in men: the MORGAM prospective cohorts. PLoS One 2012; 7: e40922.8 Wauters E, Carruthers KF, Buysschaert I, et al. Influence of 23 coronary artery disease variants on recurrent myocardial infarction or cardiac death: the GRACE Genetics Study. Eur Heart J 2013; 34: 993–1001. 9 Virani SS, Brautbar A, Lee VV, et al. Chromosome 9p21 single nucleotide polymorphisms are not associated with recurrent myocardial infarction in patients with established coronary artery disease. Circ J 2012; 76: 950–56. 10 Cholesterol Treatment Trialists’(CTT) Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials. Lancet 2010; 376: 1670–78.
